Citius Oncology growth metrics data for the quarter ended Jun 2026. These growth metrics cover 9 quarters of results from Mar 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Mar2024 | Jun2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|
| Growth Ratios | |||||||||
| EBITDA Margin (QoQ) | -158300.00 | 113,263.00 | |||||||
| EBIT Margin (QoQ) | -158300.00 | 113,263.00 | |||||||
| EBT Margin (QoQ) | -147623.00 | 100,526.00 | |||||||
| FCF Margin (QoQ) | -4333.00 | 4,835.00 | |||||||
| Gross Margin (QoQ) | 28.00 | -1320.00 | |||||||
| Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) | -742.08% | ||||||||
| Interest Coverage Ratio (QoQ)Interest Cover (QoQ) | -39.29% | -656.06% | 95.66% | ||||||
| Net Margin (QoQ) | -145566.00 | 99,858.00 | |||||||
| Operating Margin (QoQ) | -158300.00 | 113,263.00 | |||||||
| Return on Assets [ROA] Growth (1y)ROA Growth (1y) | -3065.00 | -1694.00 | 2,283.00 | 1,795.00 | 174.00 | -606.00 | |||
| Return on Assets [ROA] (QoQ)ROA (QoQ) | -1545.00 | -3491.00 | -174.00 | 486.00 | 1,153.00 | 329.00 | -1794.00 | -294.00 | |
| Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) | -4732.00 | -5796.00 | -4221.00 | 2,029.00 | -2553.00 | -1455.00 | |||
| Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) | -26.00 | -3251.00 | -1089.00 | -1677.00 | 3,456.00 | 1,338.00 | -5671.00 | -579.00 | |
| Return on Invested Capital [ROIC] Growth (1y)ROIC Growth (1y) | 1,382.00 | -1852.00 | -2436.00 | ||||||
| Return on Invested Capital [ROIC] (QoQ)ROIC (QoQ) | -1389.00 | -2115.00 | 3,430.00 | 1,457.00 | -4624.00 | -2699.00 | |||
| Return on Sales [ROS] (QoQ)ROS (QoQ) | -158300.00 | 113,263.00 |